Works by MALECKA-PANAS, E.

Results: 19

Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.

Published in:

2016

By:

Gasiorowska, A.;
Talar-Wojnarowska, R.;
Kaczka, A.;
Borkowska, A.;
Czupryniak, L.;
Małecka-Panas, E.;
Małecka-Panas, E

Publication type:

journal article

ROLE OF ADIPOKINES IN THE ASSESSMENT OF SEVERITY AND PREDICTING THE CLINICAL COURSE OF ACUTE PANCREATITIS.

Published in:

Journal of Physiology & Pharmacology, 2020, v. 71, n. 5, p. 1, doi. 10.26402/jpp.2020.5.01

By:

WOS-WRONIEWICZ, E.;
CABAN, M.;
MALECKA-PANAS, E.

Publication type:

Article

CLINICAL SIGNIFICANCE OF ACTIVIN A AND MYOSTATIN IN PATIENTS WITH PANCREATIC ADENOCARCINOMA AND PROGRESSIVE WEIGHT LOSS.

Published in:

Journal of Physiology & Pharmacology, 2020, v. 71, n. 1, p. 105, doi. 10.26402/jpp.2020.1.10

By:

TALAR-WOJNAROWSKA, R.;
WOZNIAK, M.;
BORKOWSKA, A.;
OLAKOWSKI, M.;
MALECKA-PANAS, E.

Publication type:

Article

Randomised clinical trial: the efficacy and safety of propionyl- l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 9, p. 1088, doi. 10.1111/j.1365-2036.2011.04844.x

By:

Mikhailova, T. L.;
Sishkova, E.;
Poniewierka, E.;
Zhidkov, K. P.;
Bakulin, I. G.;
Kupcinskas, L.;
Lesniakowski, K.;
Grinevich, V. B.;
Malecka‐Panas, E.;
Ardizzone, S.;
D'Arienzo, A.;
Valpiani, D.;
Koch, M.;
Denapiene, G.;
Vago, G.;
Fociani, P.;
Zerbi, P.;
Ceracchi, M.;
Camerini, R.;
Gasbarrini, G.

Publication type:

Article

A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 10, p. 1152, doi. 10.1111/j.1365-2036.2011.04631.x

By:

Gubergrits, N.;
Malecka‐Panas, E.;
Lehman, G. A.;
Vasileva, G.;
Shen, Y.;
Sander‐Struckmeier, S.;
Caras, S.;
Whitcomb, D. C.

Publication type:

Article

Cumulative effects of genetic markers and the detection of advanced colorectal neoplasias by population screening.

Published in:

Clinical Genetics, 2015, v. 88, n. 3, p. 234, doi. 10.1111/cge.12481

By:

Kurlapska, A.;
Serrano‐Fernández, P.;
Baszuk, P.;
Gupta, S.;
Starzyńska, T.;
Małecka‐Panas, E.;
Dabrowski, A.;
Dębniak, T.;
Kurzawski, G.;
Suchy, J.;
Rogoza‐Mateja, W.;
Scott, R.J.;
Lubiński, J.

Publication type:

Article

The position of a duodenal diverticulum in the area of the major duodenal papilla and its potential clinical implications.

Published in:

2021

By:

Jakubczyk, E.;
Pazurek, M.;
Mokrowiecka, A.;
Woźniak, B.;
Małecka-Panas, E.;
Podgórski, M.;
Polguj, M.;
Topol, M.

Publication type:

journal article

DNA damage in human colonic mucosa cells evoked by nickel and protective action of quercetin – Involvement of free radicals?

Published in:

Cell Biology & Toxicology, 2002, v. 18, n. 4, p. 279, doi. 10.1023/A:1016059112829

By:

Blasiak, J.;
Arabski, M.;
Pertyński, T.;
Malecka-Panas, E.;
Woźniak, K.;
Drzewoski, J.

Publication type:

Article

Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors.

Published in:

Journal of Crohn's & Colitis, 2017, v. 11, n. 8, p. 988, doi. 10.1093/ecco-jcc/jjx043

By:

Sałaga, M.;
Mokrowiecka, A.;
Jacenik, D.;
Cygankiewicz, A. I.;
Małecka-Panas, E.;
Kordek, R.;
Krajewska, W. M.;
Sobocinska, M. K.;
Kamysz, E.;
Fichna, J.

Publication type:

Article

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

Published in:

Journal of Crohn's & Colitis, 2014, v. 8, n. 9, p. 998, doi. 10.1016/j.crohns.2014.01.025

By:

Sałaga, M.;
Mokrowiecka, A.;
Zakrzewski, P. K.;
Cygankiewicz, A.;
Leishman, E.;
Sobczak, M.;
Zatorski, H.;
Małecka-Panas, E.;
Kordek, R.;
Storr, M.;
Krajewska, W. M.;
Bradshaw, H. B.;
Fichna, J.

Publication type:

Article

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Published in:

International Journal of Cancer, 2019, v. 145, n. 3, p. 686, doi. 10.1002/ijc.32127

By:

Obazee, O.;
Archibugi, L.;
Andriulli, A.;
Soucek, P.;
Małecka‐Panas, E.;
Ivanauskas, A.;
Johnson, T.;
Gazouli, M.;
Pausch, T.;
Lawlor, R. T.;
Cavestro, G. M.;
Milanetto, A. C.;
Di Leo, M.;
Pasquali, C.;
Hegyi, P.;
Szentesi, A.;
Radu, C. E.;
Gheorghe, C.;
Theodoropoulos, G. E.;
Bergmann, F.

Publication type:

Article

Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection.

Published in:

International Journal of Colorectal Disease, 2003, v. 18, n. 2, p. 148, doi. 10.1007/s00384-002-0420-9

By:

Bombski, G.;
Gasiorowska, A.;
Orszulak-Michalak, D.;
Neneman, B.;
Kotynia, J.;
Strzelczyk, J.;
Janiak, A.;
Malecka-Panas, E.

Publication type:

Article

Cover Image.

Published in:

Neurogastroenterology & Motility, 2018, v. 30, n. 5, p. 1, doi. 10.1111/nmo.13377

By:

Mosińska, P.;
Jacenik, D.;
Sałaga, M.;
Wasilewski, A.;
Cygankiewicz, A.;
Sibaev, A.;
Mokrowiecka, A.;
Małecka‐Panas, E.;
Pintelon, I.;
Storr, M.;
Timmermans, J. P.;
Krajewska, W. M.;
Fichna, J.

Publication type:

Article

FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS.

Published in:

Neurogastroenterology & Motility, 2018, v. 30, n. 5, p. 1, doi. 10.1111/nmo.13272

By:

Mosińska, P.;
Jacenik, D.;
Sałaga, M.;
Wasilewski, A.;
Cygankiewicz, A.;
Sibaev, A.;
Mokrowiecka, A.;
Małecka‐Panas, E.;
Pintelon, I.;
Storr, M.;
Timmermans, J. P.;
Krajewska, W. M.;
Fichna, J.

Publication type:

Article

Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS.

Published in:

Neurogastroenterology & Motility, 2014, v. 26, n. 11, p. 1539, doi. 10.1111/nmo.12390

By:

Fichna, J.;
Sobczak, M.;
Mokrowiecka, A.;
Cygankiewicz, A. I.;
Zakrzewski, P. K.;
Cenac, N.;
Sałaga, M.;
Timmermans, J.‐P.;
Vergnolle, N.;
Małecka‐Panas, E.;
Krajewska, W. M.;
Storr, M.

Publication type:

Article

Transient Receptor Potential Vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?

Published in:

Neurogastroenterology & Motility, 2012, v. 24, n. 11, p. e557, doi. 10.1111/j.1365-2982.2012.01999.x

By:

Fichna, J.;
Mokrowiecka, A.;
Cygankiewicz, A. I.;
Zakrzewski, P. K.;
Małecka-Panas, E.;
Janecka, A.;
Krajewska, W. M.;
Storr, M. A.

Publication type:

Article

Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients.

Published in:

European Psychiatry, 2021, v. 64, p. S554, doi. 10.1192/j.eurpsy.2021.1478

By:

Sochal, M.;
Bialasiewicz, P.;
Gabryelska, A.;
Fichna, J.;
Talar-Wojnarowska, R.;
Małecka-Panas, E.

Publication type:

Article

Increased activation of EGF-receptor tyrosine kinase by EGF and TGF-alpha in the colonic mucosa of aged rats.

Published in:

1996

By:

Malecka-Panas, E;
Relan, N K;
Majumdar, A P

Publication type:

journal article

Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission.

Published in:

Journal of Molecular Medicine, 2015, v. 93, n. 12, p. 1297, doi. 10.1007/s00109-015-1336-5

By:

Fichna, J.;
Poole, D.;
Veldhuis, N.;
MacEachern, S.;
Saur, D;
Zakrzewski, P.;
Cygankiewicz, A.;
Mokrowiecka, A.;
Małecka-Panas, E.;
Krajewska, W.;
Liedtke, W.;
Steinhoff, M.;
Timmermans, J-P.;
Bunnett, N.;
Sharkey, K.;
Storr, M.

Publication type:

Article